APA (7th ed.) Citation

GBE, S., SM, E., K, W., D, L., I, R., B, Y., . . . A, C. (2023). Domain-based mRNA vaccines encoding spike protein N-terminal and receptor binding domains confer protection against SARS-CoV-2. Science translational medicine, 15(713), eadf4100. https://doi.org/10.1126/scitranslmed.adf4100

Chicago Style (17th ed.) Citation

GBE, Stewart-Jones, et al. "Domain-based MRNA Vaccines Encoding Spike Protein N-terminal and Receptor Binding Domains Confer Protection Against SARS-CoV-2." Science Translational Medicine 15, no. 713 (2023): eadf4100. https://doi.org/10.1126/scitranslmed.adf4100.

MLA (9th ed.) Citation

GBE, Stewart-Jones, et al. "Domain-based MRNA Vaccines Encoding Spike Protein N-terminal and Receptor Binding Domains Confer Protection Against SARS-CoV-2." Science Translational Medicine, vol. 15, no. 713, 2023, p. eadf4100, https://doi.org/10.1126/scitranslmed.adf4100.